In November, 2018 I took up my first position as an in-house patent attorney, having spent almost 20 years prior in private practice at large and small firms. 

I had spent the early part of my career as a scientist, working on development of computational methods applied to drug discovery.  After I made the change into patent law, I used my technical background in both chemistry and scientific computing to pursue patent protection on behalf of clients in a variety of disciplines, including pharmaceutical and process chemistry, materials science, bioinformatics, and medical devices. 

In private practice I started as a law clerk at the Pennie & Edmonds firm, staying there as an associate attorney until the firm dissolved in 2003.  I went on to be an associate at Morgan Lewis & Bockius, and at Fish & Richardson, before becoming a principal in 2008.  After a number of years working at a virtual firm, I rejoined “biglaw” in 2017 as a Senior Counsel at McDermott Will & Emery. 

Now in-house at Genentech, I am managing patent portfolios around a number of the company’s pharmaceutical assets, in both early- and late-stage development. 

I have always maintained an interest in the ethics and malpractice side of patent practice, and have lectured on this subject at a variety of venues, including PLI. 

I have also lectured frequently on various aspects of patent case law at the American Chemical Society’s twice yearly national meetings, and currently chair the society’s “Chemistry and the Law” division. 

My educational background comprises a Bachelor’s degree and Ph.D. from the University of Cambridge, U.K., and a J.D. from Santa Clara University School of Law.  I am admitted to practice in California and District of Columbia, as well as licensed to practice before the U.S. Patent and Trademark Office.